Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cytokinetics Incorporated logo

Cytokinetics Incorporated

Sector: Healthcare   

Industry: Biotechnology

33.36
 
USD
  
-0.27
  
(-0.80%)
Optionable: Yes  Market Cap: 3,443 M  90-day average vol: 964,003

Previous close: 33.63  Open: 33.37  Bid: 33.69  Ask: 33.69
52 week range    
32.96   
   55.80
Peers   
ABIO / 
LGND / 
ACOR / 
TRVN / 
AMGN / 
Last updated: Sunday 26th March 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABIO

0 B-1.21.94

ACOR

0 B-0.11.91

AMGN

0.0347129 B23.4223.53

ARRY

2 B-38.79.53

LGND

2 B31.2124.04

TRVN

0 B-1.80.5074
Financials

CYTK Income Statement

Annual
Save
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Total revenues31 M47 M29 M106 M13 M32 M27 M56 M70 M95 M
Cost of sales-433000-490000-589000-741000-2 M-1 M-1 M95 M158 M235 M
Gross operating profit31 M47 M29 M106 M13 M32 M27 M-41 M-90 M-146 M
Selling Gen & administrative expense15 M17 M20 M28 M36 M31 M40 M53 M97 M178 M
Research & development expense49 M44 M46 M60 M90 M89 M86 M97 M160 M0
Operating income-34 M-15 M-37 M19 M-113 M-89 M-99 M-94 M-186 M-324 M
floaterest income0000000000
floaterest expense0000000000
Other income net0000000-1840000-25 M
Pre-tax Income (EBT)-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M-389 M
Income taxes0000000000
Net income from total operations-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M-389 M
Minority floaterest0000000000
Total net income-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M-389 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-34 M-15 M-38 M16 M-128 M-106 M-122 M-127 M-215 M-389 M
Depreciation4330004900005890007410002 M1 M1 M2 M2 M6 M
Amortization0000000000
Operating income before depreciation (EBITDA)-33 M-14 M-37 M20 M-109 M-83 M-93 M-87 M-184 M-332 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-1.24-0.41-0.970.41-2.59-1.95-2.11-1.97-2.8-4.33
Diluted EPS total-1.24-0.41-0.970.39-2.59-1.95-2.11-1.97-2.8-4.33
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today